Dicerna Pharmaceuticals Dicerna Pharmaceuticals
  • Our Company
    • Management Team
    • Board of Directors
    • Partnering
    • Intellectual Property
  • Our Technology
    • About RNAi
    • Our Therapy Platform
    • Glossary of Key Terms
  • Pipeline
    • About Primary Hyperoxaluria
      • About DCR-PHXC
    • Compassionate Use Policy
  • Patients
  • Investors & Media
    • Press Releases
      • Press Coverage
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact
  • Our Company
    • Management Team
    • Board of Directors
    • Partnering
    • Intellectual Property
  • Our Technology
    • About RNAi
    • Our Therapy Platform
    • Glossary of Key Terms
  • Pipeline
    • About Primary Hyperoxaluria
      • About DCR-PHXC
    • Compassionate Use Policy
  • Patients
  • Investors & Media
    • Press Releases
      • Press Coverage
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact
  • News
  • Careers
  • Contact
Home  /  
Site Map

Site Map

Site Map

  • Dicerna™ Pharmaceuticals
  • Cookies Policy
  • Dicerna PHYOX Forum
  • Event Registration
  • Job Board
  • OHF Webinar – Hebrew
  • Our Company
    • Board of Directors
    • Intellectual Property
    • Management Team
    • Partnering
  • Patients
  • PHYOX Reception Event Registration
  • Pipeline
    • About Primary Hyperoxaluria
    • About DCR-PHXC
    • Compassionate Use Policy
  • Our Technology
    • About RNAi
    • Glossary of Key Terms
    • Our Therapy Platform
  • Investors & Media
  • Careers
  • Careers – New
  • Contact
  • Copyright Info
  • News
  • Privacy Policy
  • Site Map
  • Terms of Use
Dicerna Pharmaceuticals Dicerna Pharmaceuticals

Our Mission

DicernaTM Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, viral infectious diseases, chronic liver diseases, and cardiovascular diseases.

  • Our Company
  • Our Technology
  • Pipeline
  • Patients
  • Investors & Media
  • News
  • Careers
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Copyright Info
  • Terms of Use
  • Site Map

©2019 Dicerna Pharmaceuticals, Inc.  /  Lexington, MA

Close

Privacy/Cookie Policy
& User Agreement

Cookies are pieces of data created when you visit a website. They are stored on your computer and are sent back to the website or to another website that recognizes the cookie. For more information please, refer to our Cookies Policy. Click here to accept these terms.

Accept